Bangkok: AstraZeneca (Thailand) Ltd., a leading global biopharmaceutical company, today announced the appointment of Mr. John Serry as Country President, Thailand and Frontier Markets. In this role, he will oversee AstraZeneca's overall operations in Thailand and Frontier Markets, including Bangladesh, Brunei, Cambodia, Maldives, Myanmar, and Sri Lanka. He will also lead the company's strategy to accelerate growth, innovation, and patient access. John brings extensive international leadership
Jaspal Plc. appoints Damien Corcoran as Chief Executive Officer to lead the company's next chapter of growth
—
Jaspal Public Company Limited announced the...
PTTEP marks Thailand's first Total Wellhead Platform Reuse, optimizing time and cost while maximizing resource value through circular economy
—
PTTEP has s...
Absolute Hotel Services MEA Announces Handover of U Sahl Hasheesh, Marking Third Signing in Egypt and MEA Region
—
Absolute Hotel Services Middle East & A...
Jaspal Group champions 'The Power of Next' with support for thesis fashion shows from five leading institutions
—
Jaspal Group has reaffirmed its commitme...
SiS Establishes First Clean Energy Hub in Eastern Thailand, Expands Nationwide Distribution Network to 10 Locations
—
SiS Distribution (Thailand) Public C...
MR. D.I.Y. Holding (Thailand) is selected for inclusion in SET50 and SETWB Indices
—
BANGKOK, Thailand 18 June 2026 MR. D.I.Y. Holding (Thailand) Public C...
Bangkok's Premium Co-Working Space, "The Great Room" Becomes Industrious
—
The move brings the company's Bangkok locations, previously operating as The Gr...
MSC Receives Award for Promoting Employment of the Blind, Reinforcing Commitment to Sustainable Growth
—
Metro Systems Corporation Public Company Limited ...